2Murakami Y, Okamoto M, Nakayama R. Atrial late potential (ALP) by P wave-triggered signal-averaged electrocardiogram [ J ]. Nihon Rinsho, 1995,53 (2) :353 - 359.
3Guidera SA, Steinberg JS. The signal-averaged P wave duration : a rapid and noninvasive marker of risk of atrial fibrillation [ J ]. J Am Coll Cardiol, 1993,21 (7) : 1645 - 1651.
4Fukunami M, Yamada T, Ohmori M, et al. , Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave- triggered signal-averaged electrocardiogram [ J ]. Circulation, 1991, 83( 1 ) :162 - 169.
9Hinton RC, Kistler JP, Fallon JT, et al. Influence of etiology of atrial fibrillation on incidence of systemic embolism [ J ]. Am J Cardiol, 1977,40(4) :509 -513.
10Wolf PA, Dawber TR, Thomas HE Jr, et al. Epidemiologic assess- ment of chronic atrial fibriUation and risk of stroke : the Framingham study [ J ]. Neurology, 1978,28 (10) :973 - 977.
6WHO/ISH Guidelines Committee. 1999 World Health Organization International Society of Hypertension Guidelines fnr the Management of Hypertension[J]. Blood Press, 1999,1 Suppl: 9 - 34.
7Gcette A, Staack T, Rocken C, et al. Increased expression of extra cellular signal-regnlated Kinase and angiotensin-converting enzyme in human atria during atrial Fibrillation[J]. J Am Col Cardiol, 2000, 35(6):1669- 1677.
8Fogari R. Iosartan and prevention of atrial fibrillation inhypetrensive patients[J]. Journal of Cardiovascular Pharmacology and therapeutics, 2006, 47:46-50.
9谌利群，山东师范大学学报，1994年，9卷，增刊2期，37页
10Olgin JE,Kalman JM,Fitzpatrick AP,et al.Role of right atrial endocardial structures as barriers to condution during human type I atrial flutter,activagion andentrainment mapping guided by intracardiac echocardiography[J].Circulation,1995,92:1893.
